First In Human News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First in human phase I clinical study using OMV as an adjuvant for intranasal vaccinationAvacc 10® intranasal booster vaccine induces a mucosal response and no adverse eventsData will be presented at the World Vaccine Conference on April 3rd 2024 in Washington, DC BILTHOVEN, The Netherlands, March 26, 2024 (GLOBE NEWSWIRE) -- Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines, today announced positive clinical data of a first in human (FIH)

Kaneka Corporation has acquired all shares of Japan Medical Device Technology Co., Ltd. , a developer and manufacturer of medical devices, on November 30, 2023, and made it a wholly owned...

Lee, MA, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Berkshire Sterile Manufacturing (BSM) is pleased to announce their ninth webinar in their webinar series,...

Acute-on-chronic liver failure (ACLF) occurs in 30% of hospitalized cirrhosis patients, leading to over one million deaths worldwide each year. Currently, the only potential treatment for this condition is liver transplantation, which is available to very few patients. A first-in-human randomized controlled clinical trial using DIALIVE, a novel liver dialysis device, demonstrated its potential as a disease-modifying therapy and resolved liver failure significantly faster and in a greater p...

Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY Robotic system, the first fully disposable endovascular robotic system, announced that it has